Navigation Links
Johnson & Johnson Diabetes Institute, LLC Launches New Center to Provide State-of-the-Art Education, Training to Health Professionals
Date:2/29/2008

untry. Agreeing that diabetes is reaching crisis levels, the experts cautioned that if present trends continue, one in three Americans, and one in two minorities, born in 2000 will develop diabetes in their lifetime. According to experts participating in the Town Hall, reversing these trends will require addressing the many barriers that are preventing patients and providers from achieving established treatment goals.

To identify these barriers, the new Institute recently underwrote a national survey aimed at assessing the issues and needs of health professionals who regularly treat diabetes patients at the community level. Conducted by Penn, Schoen and Berland, the survey reviewed the attitudes of 251 practitioners -- physicians, physician assistants, nurse practitioners and certified diabetes educators -- and found growing concern about the ability of health professionals to improve patient outcomes. Virtually all respondents (94 percent) say they are very worried about the impact of diabetes in their communities and more than nine in ten (91 percent) report diabetes rates have increased in their localities over the last five years. In fact, 95 percent of those surveyed consider diabetes an epidemic in their community.

But as the prevalence of diabetes increases, health professionals worry that not enough attention is being paid to diabetes management at the community level, a problem cited by 83 percent of respondents. As a consequence, these practitioners cite increasing obstacles to providing better diabetes care. Almost four in five (78 percent) identify the lack of early screenings for diabetes as a cause for the complications their patients face when they are eventually diagnosed.

Practitioners also worry about a lack of funding for community education programs and 23 percent of respondents cite this problem as the single most important obstacle to improving diabetes care. In fact, 96 percent of respondents said that additional resources
'/>"/>

SOURCE Johnson & Johnson Diabetes Institute, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers
2. First Group of Minority Nurse Faculty Scholars Selected by the Johnson & Johnson Campaign for Nursings Future and AACN
3. MUSCs Hollings Cancer Center, Ralph H. Johnson VA Medical Center Partner on New TomoTherapy Treatment for Cancer Patients
4. Ravenell named recipient of grant from Robert Wood Johnson Foundation
5. Johnson City Medical Center Begins Offering Einstein Bros. Menu Items at Second On Campus Location
6. Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
7. Bobby Rush Revue and James Super Chikan Johnson Announced for Post-Race Concert
8. Cookie Johnson and Abbott Bring I Stand With Magic: Campaign to End Black AIDS to Los Angeles to Educate African-American Women on HIV/AIDS
9. The Magic Johnson Foundation and Abbott Expand Focus of Campaign to End Black AIDS to African-American Women in 2008
10. Wendy Borow-Johnson to Join bioMETRX Board of Directors
11. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...e American Society for Gastrointestinal Endoscopy ...opy in the bariatric surgery patient. The rising p...success in surgical interventions led to a marked ...rformed in the U.S., from 13,365 in 1998 to 102,79... preoperative patient and the postoperative patien...
(Date:7/25/2008)...ent of Defense and Federal Agencies in, the execu... Phoenix is a, four-day, multi-agency collaborat...ate and local agencies with large and complex inci...a vital, ad-hoc, secure mobile communications in... NORFOLK, Va., July 25 /PRNewswire/ -- Dataline L...
(Date:7/25/2008)...The Elekta Family of Companies will,showcase their...2008,American Association of Physicists in Medicin...nt forces of Elekta, IMPAC and CMS are delivering,...ry solutions that,streamline the treatment process...ll as enhance clinician efficiency., "Our recent ...
(Date:7/25/2008)... delivers immediate cost savings for http://www.l... language interpreters] to firms switching langua... Washington, D.C. (Vocus)....com/index.html [(Language Learning Enterprises, ...slation, and language instruction services to thou...
Breaking Medicine News(10 mins):Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3
...edly found inconsistencies in President Bush's AID...leged nations, which has made it difficult, to gau...claim that the three year old AIDS program, valued...ise count of the thousands of patients the program...
...t’ll grow back within a week. //Like lizards, newt... complex body parts. A tail fin, for example, has ...ate structure. It is the fish version of an arm or... animals re-grow missing tails and other appendage...
...ting from excessive binge-alcohol drinking can be ...drug Boniva? (ibandronate), a Loyola University He...l drinking reduces bone mass, which is detrimental...ncreases the rate of bone loss in osteoporotic pos...
...’s resolutions to achieve improved health and happ...said today. “The new year is a great time to make ...nd fitness,” Dr Yong said. “Aim to keep your reso...ing ahead. “For instance, if you plan to quit smo...
Other Medicine News:Health News:Regrowth of Zebrafish's Tail Fin may Offer Clues for Treating Human Injuries 2Health News:Regrowth of Zebrafish's Tail Fin may Offer Clues for Treating Human Injuries 3Health News:Vitamin D or Anti-osteoporosis Drug Reduces Bone Loss from Binge Drinking 2Health News:Planning for Good Health Resolutions 2
(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have ...EIGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- F...through liposuction was found to be,an excellent s...rations,than other areas of the body, reports a Br...tructive Surgery(R), the official medical journal ...
(Date:7/23/2008)... SEATTLE, July 23 /- De...d that it expects the Independent Data,Monitoring ...erim analysis,of overall survival relating to the ...te AdenoCarcinoma Treatment, also known as D9902B)...VENGE is the Company,s investigational,active cell...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-Firs...ed late yesterday, the Board of Progen,Pharmaceuti...ced that it,had discontinued the PI-88 phase 3 stu... direction to develop its existing portfolio of co...ire additional compounds and,opportunities through...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Me...ring solutions for more than 20 years, has entered...technology to measure,regional oxygen saturation. ...y is the continuous monitoring of the regional blo... Early testing data and outcomes from an ongoing ...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CafePress Supports Stand Up To Cancer With Online Store to Help Raise Awareness and Funds for Research 22059 1CafePress Supports Stand Up To Cancer With Online Store to Help Raise Awareness and Funds for Research 22059 2Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 6052 1Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 6052 2Faith Haines Kolb Joins PROMETRIKA as Senior Director of Clinical Operations and Data Management 6052 3First successful reverse vasectomy on endangered species performed at the National Zoo 3662 1First successful reverse vasectomy on endangered species performed at the National Zoo 3662 2First successful reverse vasectomy on endangered species performed at the National Zoo 3662 3Wavelets crunch through doctors day long struggle to diagnose brain tumors 22053 1Wavelets crunch through doctors day long struggle to diagnose brain tumors 22053 2
... Tolerance Support Development,of Omega DUROS Cont...2, 2007 /PRNewswire/ -- Intarcia,Therapeutics, Inc...ay announced final results from a Phase 2 study of...atment-naive patients,with genotype 1 chronic hepa...eron in combination with ribavirin is well tolerat...
...11, 2007 (PRIME NEWSWIRE) --,Hana Biosciences (Nas...advancing cancer care, will present preclinical da...the American Association,for Cancer Research 100th...California. , Abstract No. 2210: "Combining talotr...ll lung cancer (NSCLC) athymic nude,mice xenograft...
Other Medicine Technology:Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 2Hana Biosciences Announces Data to be Presented On Talvesta,(Talotrexin) for Injection at The American Association for Cancer,Research Annual Meeting 3
TLS Surgical Markers allows the surgeon to effectively diagram incision sites with a scrub-resistant, gentian violet ink. All TLS Surgical Markers are provided sterile, with a ruler and are individua
Gentian violet ink stands up to pre-operative prepping, Millimeter scale ruler printed on the pen's barrel for quick measuring. Flexible, smudge-proof two-sided ruler with both inch and metric scales
Broad tip, gentian violet, sterile, disposable
Double-ended, one end sharp, other end blunt, 7 1/2", double-ended, 5 mm wide.
Medicine Products: